REFERENCES
- Aranha O., Wood D P., Sarkar F. H. Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin Cancer Res 2000; 6: 891–900, [PUBMED], [INFOTRIEVE], [CSA]
- Aranha O., Zhu L., Alhasan S., Wood D. P., Kuo T. H., Sarkar F. H. Role of mitochondria in ciprofloxacin induced apoptosis in bladder cancer cells. J. Urology 2002; 167: 1288–1294, [CSA], [CROSSREF]
- Chai F., Truong-tran A. Q., Ho L. H., Zalewski P. D. Regulation of caspase activation and apoptosis by cellular zinc fluxes and zinc deprivation: A review. Immunol Cell Biol 1999; 77: 272–278, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Christ W. Central nervous system toxicity of quinolones: human and animal findings. J Antimicrob Chemother 1990; 26(Suppl B)219–25, [PUBMED], [INFOTRIEVE], [CSA]
- Forsgren A., Bredberg A., Pardee A. B., Schlossman S. F., Tedder T. F. Effects of ciprofloxacin on eukaryotic pyrimidine nucleotide biosynthesis and cell growth. Antimicrob Agents Chemother 1987; 31: 774–79, [PUBMED], [INFOTRIEVE], [CSA]
- Fraker P. J., Telford W. G. A reappraisal of the role of zinc in life and death decision of cells. Proc. Soc. Exp. Biol. Med. 1997; 215: 229–236, [PUBMED], [INFOTRIEVE], [CSA]
- Frankel A. D., Bredt D. S., Pabo C. O. Tat protein from human immunodeficiency virus forms a metal-linked dimmer. Science 1988; 240: 70–73, [PUBMED], [INFOTRIEVE], [CSA]
- Frankel A. D., Chen L., Cotter R. J., Pabo C. O. Dimerization of the tat protein from human immunodeficiency virus: A cycteine-rich peptide mimics the normal metal-linked dimmer interface. Proc Natl Acad Sci USA 1988; 85: 6297–6300, [PUBMED], [INFOTRIEVE], [CSA]
- Gellert M., Mizuuchi K., O'Dea M. H., Itoh T., Tomizawa J. I. Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc Natl Acad Sci USA 1977; 74: 4772–76, [PUBMED], [INFOTRIEVE], [CSA]
- Gootz T. D., Barret J. F., Holden H. E., Ray V. A., McGuirk P. R. Selective toxicity: the activity of 4-quinolones against eukaryotic DNA topoisomerase. The 4-quinolones: antibacterial agents in vitro, G Crumplin. Springer-Verlag, London 1990; 159–171
- Grayson M L. The Use of antibiotics: a clinical review of antibacterial, antifungal, and antiviral drugs, A. Kucers, 1999; 981–1060
- Gürbay A, Gonthier B, Favier A, Hncal F. Ciprofloxacin-induced cytotoxicity in primary cell cultures of rat astrocytes. “Abstracts of EUROTOX 2001'”. Toxicology Letters 2001b; 123(Suppl. 1)137, [CSA]
- Gürbay A., Garrel C., Osman M., Richard M -J., Favier A., Hincal F. Cytotoxicity in ciprofloxacin-treated human fibroblast cells and protection by vitamin E. Human & Experimental Toxicology 2002; 21: 635–641, [CSA], [CROSSREF]
- Gürbay A., Gonthier B., Daveloose D., Favier A., Hincal F. Microsomal metabolism of ciprofloxacin generates free radicals. Free Radical Biol Med 2001; 30: 1118–1121, [CSA], [CROSSREF]
- Gürbay A., Hincal F. Ciprofloxacin-induced glutathione redox status alterations in rat tissues Accepted for publication. Drug and Chemical Toxicology 2004; volume 27(issue 3), [CSA]
- Hayem G., Petit P. X., Levacher M., Gaudhin C., Kahn M -F., Pocidalo J -J. Cytofluorometric analysis of chondrotoxicity of fluoroquinolone antimicrobial agents. Antimicrob Agents Chemother 1994; 38: 243–247, [PUBMED], [INFOTRIEVE], [CSA]
- Herold C., Ocker M., Ganslmayer M., Gerauer H., Hahn E. G., Schuppan D. Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells. Br J Cancer 2002; 86: 443–448, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Höffken G., Borner K., Glatzel P. D., Koeppe P., Lode H. Reduced enteral absorption of ciprofloxacin in the presence of antacids. Eur J Clin Microbiol 1985; 4: 345, [CSA]
- Hooper D. C., Wolfson J. S. The fluoroquinolones: pharmacology, clinical uses, and toxicities in human. Antimicrob Agents Chemother 1985; 28: 716–721, [PUBMED], [INFOTRIEVE], [CSA]
- Hussy P., Maass G., Tummler B., Grosse F., Schomburg U. Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase a primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts. Antimicrob Agents Chemother 1986; 29: 1073–78, [PUBMED], [INFOTRIEVE], [CSA]
- Jun Y -T., Kim H -J., Song M -J., Lim J -H., Lee D -G., Han K -J., Choi S -M., Yoo J -H., Shin W -S., Choi J -H. In vitro effects of ciprofloxacin and roxithromycin on apoptosis of Jurkat T lymphocytes. Antimicrob Agents Chemother 2003; 47: 1161–1164, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lawrence J. W., Claire D. C., Weisis V., Rowe T. C. Delayed cytotoxicity and cleavage of mitochondrial DNA in ciprofloxacin-treated mammalian cells. Mol Pharmacol 1996; 50: 1178–1188, [PUBMED], [INFOTRIEVE], [CSA]
- Lawrence J. W., Darkin-Rattay S., Xie F., Neims A. H., Rowe T. C. 4-quinolones causes a selective loss of mitochondrial DNA from mouse L1210 leukemia cells. J Cell Biochem 1993; 51: 165–174, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Li C. J., Friedman D. J., Wang C. L., Metelev V., Pardee A. B. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 1995; 268: 429–431, [PUBMED], [INFOTRIEVE], [CSA]
- Los M., Droge W, Stricker K, Baeuerle P A, Schulze-Osthoff K. Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur J Immunol 1995; 25: 159–65, [PUBMED], [INFOTRIEVE], [CSA]
- Multhaupt H. A.B., Alvarez J. C., Rafferty P. A., Warhol M. J.L., Ackman R. D. Fluoroquinolone's effect on growth of human chondrocytes and chondrosarcomas. J Bone & Joint Surg 2001; 83-A(Suppl 2)56–61, [CSA]
- Murrell G. A., Francis M. J.O., Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 1990; 265: 659–65, [PUBMED], [INFOTRIEVE], [CSA]
- Nordmann P., Pechinot A., Kazmierczak A. Cytotoxicity and uptake of pefloxacin, ciprofloxacin, and ofloxacin in primary cultures of rat hepatocytes. J Antimicrob Chemother 1989; 24: 355–63, [PUBMED], [INFOTRIEVE], [CSA]
- Oomori Y., Yasue T., Aoyama H., Iwamoto K. Effects of fleroxacin on HeLa cell functions and topoisomerase II. J Antimicrob Chemother 1988; 22(Suppl)91–97, [PUBMED], [INFOTRIEVE], [CSA]
- Perry D. K., Smyth M. J., Stennicke H. R., Salvesen G. S., Duriez P., Poirier G. G., Hannun Y. Zinc is a potent inhibitor of the apoptotic protease, caspase-3. J Biol Chem 1997; 272: 18530–18533, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schafer D., Hamm-Kunzelmann B., Hermfisse U., Brand K. Differences in DNA-binding efficiency of Sp 1 to aldolase and pyruvate kinase promoter correlate with altered redox states in resting and proliferating rat thymocytes. FEBS Lett 1996; 391: 35–38, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Seve M., Favier A., Osman M., Hernandez D., Vaitaitis G., McFlores N. C., Cord J. M., Flores S. C. The human immunodeficiency virus-1 tat protein increases sensitivity to zinc chelatorinduced apoptosis and changes Sp1 DNA binding in HeLa cells. Arch Biochem Biophys 1999; 351: 165–72, [CSA], [CROSSREF]
- Stahlmann R., Lode H. Toxicity of quinolones. Drugs 1999; 58(Suppl. 2)37–42, [PUBMED], [INFOTRIEVE], [CSA]
- Truong-Tran A. Q., Carter J., Ruffin R. E., Zalewski P. D. The role of zinc in caspase activation and apoptotic cell death. Biometals 2001; 14: 315–330, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wagai N, Tawara K. Possible reasons for difference in phototoxic potential of 5-quinolone antibacterial agents: generation of toxic oxygen. Free Radical Res Commun 1992; 17: 387–398, [CSA]
- Zauli G., Gibellini D., Milani D., Mazzoni M., Borgatti P., Laplaca M., Capitani S. Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res. 1993; 53: 4481–4485, [PUBMED], [INFOTRIEVE], [CSA]